Volteface Team

A new report has revealed that approximately 29.6 million people (50.2%) in the UK could be entitled to a medicinal cannabis prescription, yet just 0.048% of the population has been…

This month, medicinal cannabis organisation Cancard announced a collaborative project with Grow Lab Organics to enable a licensed medicinal cannabis farm to become a community owned endeavour, the first of…

Volteface and The Medical Cannabis Clinicians Society (MCCS) have been successfully elected as the new secretariat for the medical cannabis on prescription APPG – bringing new bold strategy and commitment…

On 12th April 2023, Minister of Health, Dr. Karl Lauterbach, and Federal Minister of Food and Agriculture, Cem Özdemir, held a press conference to announce the  updated German approach to legalised adult…

Medical cannabis was legalised in the UK on 1st November 2018, following years of extensive campaigning. However, over half of the British public are still unaware that they can legally…

Yesterday, the UK government confirmed plans to ban nitrous oxide or NOS, and reschedule it as a Class C drug, ignoring the advice of the its own Advisory Council on the…

After taking some time off due to becoming a father, Clark French, founder of the United Patients Alliance, is relaunching the patient-focused organisation at the Brighton Medicinal Cannabis Summit 2023.…

The UK’s largest medical cannabis company has announced a new capital raise and the completion of an internal restructure.  This new raise will support Lyphe Group to become cash flow…

The potential of cannabis medicines to treat symptoms of epilepsy, especially for children who are resistant to other available drugs, has been one of the driving forces behind the liberalisation…

DM for Details: Selling Drugs in the Age of Social Media You can download the full report here  Executive Summary Introduction In this report, Volteface aims to bridge the gap in…